Darrell Wu1, Pingping Ren1, Yanqiu Zheng1, Lin Zhang1, Gaiping Xu1, Wanmu Xie1, Eric E Lloyd1, Sui Zhang1, Qianzi Zhang1, John A Curci1, Joseph S Coselli1, Dianna M Milewicz1, Ying H Shen1, Scott A LeMaire2. 1. From the Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery (D.W., P. R., Y.Z., L.Z., G.X., W.X., J.S.C., Q.Z., Y.H.S., S.A.L.), Cardiovascular Research Institute (J.S.C., Y.H.S., S.A.L.), and Department of Molecular Physiology and Biophysics (D.W., E.E.L., S.A.L.), Baylor College of Medicine, Houston, TX; Department of Cardiovascular Surgery, Texas Heart Institute, Houston (D.W., P.R., G.X., L.Z., W.X., J.S.C., Y.H.S., S.A.L.); Cardiology MD Anderson Cancer Center, Houston, Texas (S.Z.); Division of Vascular Surgery, Vanderbilt University School of Medicine, Nashville, TN (J.A.C.); and Division of Medical Genetics, Department of Internal Medicine, The University of Texas Health Science Center at Houston (D.M.M). 2. From the Division of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery (D.W., P. R., Y.Z., L.Z., G.X., W.X., J.S.C., Q.Z., Y.H.S., S.A.L.), Cardiovascular Research Institute (J.S.C., Y.H.S., S.A.L.), and Department of Molecular Physiology and Biophysics (D.W., E.E.L., S.A.L.), Baylor College of Medicine, Houston, TX; Department of Cardiovascular Surgery, Texas Heart Institute, Houston (D.W., P.R., G.X., L.Z., W.X., J.S.C., Y.H.S., S.A.L.); Cardiology MD Anderson Cancer Center, Houston, Texas (S.Z.); Division of Vascular Surgery, Vanderbilt University School of Medicine, Nashville, TN (J.A.C.); and Division of Medical Genetics, Department of Internal Medicine, The University of Texas Health Science Center at Houston (D.M.M). slemaire@bcm.edu hyshen@bcm.edu.
Abstract
OBJECTIVE: Increasing evidence suggests that contractile dysfunction in smooth muscle cells (SMCs) plays a critical role in aortic biomechanical dysfunction and aortic aneurysm and dissection (AAD) development. However, the mechanisms underlying SMC contractile dysfunction in sporadic AAD are poorly understood. In this study, we examined the role of the NLRP3 (nucleotide oligomerization domain-like receptor family, pyrin domain containing 3)-caspase-1 inflammasome, a key inflammatory cascade, in SMC contractile dysfunction in AAD. APPROACH AND RESULTS: We observed significant SMC contractile protein degradation in aortas from patients with sporadic thoracic AAD. The contractile protein degradation was associated with activation of the NLRP3-caspase-1 inflammasome cascade. In SMCs, caspase-1 bound and directly cleaved and degraded contractile proteins, leading to contractile dysfunction. Furthermore, Nlrp3 or caspase-1 deficiency in mice significantly reduced angiotensin II-induced contractile protein degradation, biomechanical dysfunction, and AAD formation in both thoracic and abdominal aortas. Finally, blocking this cascade with the inflammasome inhibitor, glyburide (an antidiabetic medication), reduced angiotensin II-induced AAD formation. CONCLUSIONS: Inflammasome-caspase-1-mediated degradation of SMC contractile proteins may contribute to aortic biomechanical dysfunction and AAD development. This cascade may be a therapeutic target in AAD formation. In addition, glyburide may have protective effects against AAD development.
OBJECTIVE: Increasing evidence suggests that contractile dysfunction in smooth muscle cells (SMCs) plays a critical role in aortic biomechanical dysfunction and aortic aneurysm and dissection (AAD) development. However, the mechanisms underlying SMC contractile dysfunction in sporadic AAD are poorly understood. In this study, we examined the role of the NLRP3 (nucleotide oligomerization domain-like receptor family, pyrin domain containing 3)-caspase-1 inflammasome, a key inflammatory cascade, in SMC contractile dysfunction in AAD. APPROACH AND RESULTS: We observed significant SMC contractile protein degradation in aortas from patients with sporadic thoracic AAD. The contractile protein degradation was associated with activation of the NLRP3-caspase-1 inflammasome cascade. In SMCs, caspase-1 bound and directly cleaved and degraded contractile proteins, leading to contractile dysfunction. Furthermore, Nlrp3 or caspase-1 deficiency in mice significantly reduced angiotensin II-induced contractile protein degradation, biomechanical dysfunction, and AAD formation in both thoracic and abdominal aortas. Finally, blocking this cascade with the inflammasome inhibitor, glyburide (an antidiabetic medication), reduced angiotensin II-induced AAD formation. CONCLUSIONS: Inflammasome-caspase-1-mediated degradation of SMC contractile proteins may contribute to aortic biomechanical dysfunction and AAD development. This cascade may be a therapeutic target in AAD formation. In addition, glyburide may have protective effects against AAD development.
Authors: Dianna M Milewicz; Dong-Chuan Guo; Van Tran-Fadulu; Andrea L Lafont; Christina L Papke; Sakiko Inamoto; Carrie S Kwartler; Hariyadarshi Pannu Journal: Annu Rev Genomics Hum Genet Date: 2008 Impact factor: 8.929
Authors: S S Kang; F N Littooy; S R Gupta; G R Johnson; S G Fisher; W L Cote; G F Steffen; M A Mansour; N Labropoulos; J C Maggio Journal: Surgery Date: 1999-10 Impact factor: 3.982
Authors: Ying H Shen; Scott A LeMaire; Nancy R Webb; Lisa A Cassis; Alan Daugherty; Hong S Lu Journal: Arterioscler Thromb Vasc Biol Date: 2020-02-26 Impact factor: 8.311
Authors: Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi Journal: Physiol Rev Date: 2018-07-01 Impact factor: 37.312
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311